Current Liabilities
Other Commercial Liabilities
CVS Health Other Commercial Liabilities decreased by 0.6% to $22.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $22.37B to $22.26B. Over 5 years (FY 2020 to FY 2025), Other Commercial Liabilities shows an upward trend with a 9.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2014
Last reportedQ1 2026May 6, 2026
Metric ID:
commercial_liabilities_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.83B | $16.14B | $17.67B | $16.62B | $17.73B | $19.42B | $18.75B | $21.52B | $22.83B | $22.57B | $23.52B | $22.35B | $21.16B | $20.17B | $20.81B | $22.37B | $23.10B | $23.42B | $22.39B | $22.26B |
| QoQ Change | — | +8.9% | +9.5% | -5.9% | +6.7% | +9.6% | -3.5% | +14.8% | +6.1% | -1.1% | +4.2% | -5.0% | -5.3% | -4.7% | +3.2% | +7.5% | +3.3% | +1.4% | -4.4% | -0.6% |
| YoY Change | — | — | — | — | +19.6% | +20.3% | +6.1% | +29.5% | +28.8% | +16.2% | +25.4% | +3.9% | -7.3% | -10.6% | -11.5% | +0.1% | +9.2% | +16.1% | +7.6% | -0.5% |
Range$14.83B – $23.52B
CAGR+8.9%
Avg YoY Growth+9.5%
Median YoY Growth+8.4%
Current Streak2 quarters decline
Other Commercial Liabilities at Other Companies
Frequently Asked Questions
- What is CVS Health's other commercial liabilities?
- CVS Health (CVS) reported other commercial liabilities of $22.26B in Q1 2026.
- How has CVS Health's other commercial liabilities changed year-over-year?
- CVS Health's other commercial liabilities decreased by 0.5% year-over-year, from $22.37B to $22.26B.
- What is the long-term trend for CVS Health's other commercial liabilities?
- Over 5 years (2020 to 2025), CVS Health's other commercial liabilities has grown at a 9.5% compound annual growth rate (CAGR), from $14.24B to $22.39B.